Vivid Genomics, Inc.

-- Vivid Genomics is addressing a $50 billion market opportunity with precision medicine for dementia, with ramp to become a $1 billion company

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Founded January 2017
  • Employees 3
  • Incorporation Type C-corp
  • Website vividgenomics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free